# Filing Detail

Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001140361-22-025586
Filing Date
2022-07-08
Accepted
2022-07-08 15:51:36
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PREC14A | edge20002003x1_prec14a.htm | PREC14A | 1148071
2 |  | edge20002003x1_pc01.jpg | GRAPHIC | 962945
3 |  | edge20002003x1_pc02.jpg | GRAPHIC | 1035559
4 |  | logo_dfkingast2x1.jpg | GRAPHIC | 30241
| Complete submission text file | 0001140361-22-025586.txt |  | 3943001

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filed by) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: PREC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 000-51173 | Film No.: 221074296
SIC: 2834 Pharmaceutical Preparations